Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mod Rheumatol ; 26(4): 562-8, 2016 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-26667376

RESUMO

OBJECTIVE: Previous reports indicate that serum anti-microtubule-associated protein 2 (MAP-2) antibodies are common in sera from patients with neuropsychiatric systemic lupus erythematosus (NPSLE). Differential diagnosis of NPSLE is occasionally difficult because of differential diagnosis which can mimic NPSLE. Therefore, specific biomarkers for NPSLE are needed. We conducted this study to clarify whether cerebrospinal fluid (CSF) anti-MAP-2 antibodies are a useful diagnostic biomarker for NPSLE. METHODS: Enzyme-linked immunosorbent assay was conducted to measure CSF concentrations of anti-MAP-2 and anti-ribosomal P antibodies and of IL-6 in NPSLE patients (n = 24) and non-NPSLE controls (n = 17). The non-NPSLE controls consisted of systemic lupus erythematosus patients with neuropsychiatric symptoms caused by non-NPSLE conditions (n = 10) and patients with other connective tissue diseases (n = 7). RESULTS: Significantly higher anti-MAP-2 antibody titers were found in the CSF of patients with NPSLE versus non-NPSLE controls. The prevalence of anti-MAP-2 antibodies was 33.3% (8/24) in NPSLE patients when a positive cutoff value was 3 standard deviations above the mean optical density of non-NPSLE controls. None of the controls had anti-MAP-2 antibodies in their CSF. Both anti-ribosomal P antibody titers and concentration of IL-6 in the CSF were significantly higher in patients with NPSLE having anti-MAP-2 antibodies than in patients with non-NPSLE controls. CONCLUSION: Anti-MAP-2 antibodies could be detected in the CSF of 33.3% of patients with NPSLE, and its presence was highly specific for NPSLE. We propose that CSF anti-MAP-2 antibodies are a novel and useful diagnostic biomarker for NPSLE.


Assuntos
Autoanticorpos , Interleucina-6 , Vasculite Associada ao Lúpus do Sistema Nervoso Central , Proteínas Associadas aos Microtúbulos/imunologia , Proteínas Ribossômicas/imunologia , Adolescente , Adulto , Autoanticorpos/análise , Autoanticorpos/líquido cefalorraquidiano , Biomarcadores/análise , Biomarcadores/líquido cefalorraquidiano , Confusão/diagnóstico , Confusão/etiologia , Diagnóstico Diferencial , Feminino , Humanos , Interleucina-6/análise , Interleucina-6/líquido cefalorraquidiano , Vasculite Associada ao Lúpus do Sistema Nervoso Central/líquido cefalorraquidiano , Vasculite Associada ao Lúpus do Sistema Nervoso Central/complicações , Vasculite Associada ao Lúpus do Sistema Nervoso Central/diagnóstico , Masculino , Pessoa de Meia-Idade , Prevalência , Reprodutibilidade dos Testes , Estatística como Assunto
2.
J Rheumatol ; 42(5): 826-8, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25729029

RESUMO

OBJECTIVE: Systemic lupus erythematosus (SLE) occurs predominantly in women, and sex hormones play an important role in SLE. Variation in the second-to-fourth digit ratio (2D4D ratio) is attributed to sex hormone exposure. Therefore, we evaluated the relationship between sex hormones and SLE by measuring 2D4D ratios. METHODS: We measured 2D4D ratios in 100 patients with SLE and 200 normal healthy controls (NHC). RESULTS: Patients with SLE had a lower 2D4D ratio than NHC. CONCLUSION: Our study suggests that patients with SLE have experienced high prenatal testosterone and low prenatal estrogen. To our knowledge, this is the first study evaluating the association between 2D4D ratio and SLE.


Assuntos
Dedos/patologia , Hormônios Esteroides Gonadais/sangue , Lúpus Eritematoso Sistêmico/patologia , Efeitos Tardios da Exposição Pré-Natal/patologia , Adulto , Antropometria , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Gravidez , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...